Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fidia Farmaceutici, SpA

http://www.fidiapharma.com

Latest From Fidia Farmaceutici, SpA

Deal Watch: BMS Looks To Molecular Templates’ Engineered Toxin Bodies In Cancer

Plus recent deals involving AbbVie/Caribou, Sanofi/i2O, Merck & Co./Starpharma, Protalix/SarcoMed, Targovax/Papyrus, Medivir/Ubiquigent, Eton/Azurity

Deals M & A

NASH Drug Development Questions? US FDA Has Many Of The Answers

From biomarkers to treatment effect size, agency officials respond to some of more than a hundred questions that poured in during a webinar on development of drugs to treat the liver disease.

Metabolic Disorders FDA

Scrip Asks…What Does 2021 Hold For Biopharma? Part 4: Technology And Disease

Around 100 executives highlight the hot areas to watch on the R&D front in 2021. From cancer to CNS and from regenerative medicine to real world data, expectations are high on many fronts.

Scrip Asks Artificial Intelligence

Flow Neuroscience Buys Halo To Apply Transcranial Stimulation To Depression

Flow plans to develop Halo’s transcranial direct current stimulation technology to treat depression and other mental health disorders.

M & A Intellectual Property
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Bioos
    • Fidia Pharma Group
    • Glaucoom
    • OftaH.T. e Neoox
    • Soluciones Bioregenerativas SL
    • Sooft Italia
    • Fidia Pharma Austria GmbH
UsernamePublicRestriction

Register